Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Jade Biosciences, Inc. (JBIO) had Pre-Tax Income of $-40.35M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-40.37M |
|
-- |
|
-- |
|
$43.45M |
|
$-43.45M |
|
$3.09M |
|
|
Pre-Tax Income |
$-40.35M |
$-40.35M |
|
$-40.37M |
|
$-40.37M |
|
$-40.37M |
|
$-40.37M |
|
$-43.45M |
|
$-43.93M |
|
57.78M |
|
57.78M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$318.52M |
|
$0.16M |
|
$0.92M |
|
$319.43M |
|
$22.29M |
|
-- |
|
$0.68M |
|
$22.97M |
|
$296.46M |
|
$296.46M |
|
$296.46M |
|
49.35M |
|
| Cash Flow Statement Financials | |
$-24.08M |
|
$-8.47M |
|
$-0.80M |
|
$88.44M |
|
$55.09M |
|
$-33.35M |
|
$7.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.62% |
|
-13.62% |
|
-12.64% |
|
-13.62% |
|
$6.01 |
|
$-0.42 |
|
$-0.42 |
|